Matthew S. Wheatley

Since joining Kirkland, Matthew has been involved in the following matters:

• HGGC in its $240 million joint investment in Fullscript with Snapdragon Capital Partners.

Prior to joining Kirkland, Matthew was involved in the following matters:

• Spark Therapeutics in its +$4 billion sale to Roche.
• Beth Israel Deaconess Medical Center, Lahey Health System, New England Baptist Hospital, Mount Auburn Hospital, and Seacoast Regional Health System in their $5+ billion merger to create Beth Israel Lahey Health.
• Rainmaker in its $300 million sale of its LRO software and related assets to RealPage.
• MyoKardia in its $13.1 billion sale to Bristol Myers Squibb.
• AMAG Pharmaceuticals in its $500 million sale to Covis Group.
• Thrive Earlier Detection in its $2.15 billion sale to Exact Sciences.
• Nautic Partners in its acquisition of American Renal Associates for $863 million.
• Zoox in its acquisition by Amazon.
• TurnItIn in its $1.75 billion sale to Advance Publications.
• PillPack, Inc. in its $1 billion acquisition by Amazon.

Associate. Goodwin Procter LLP, 2017–2021

Associate, Hunton & Williams LLP, 2015–2017